Trial-based study
MAY
A DCE was performed alongside a trial (USFarmáciaThe trial was registered with Current Controlled Trials (ISRCTN): ISRCTN13410498.The Administração Regional de Saúde (ARS Centro) [Regional Health Administration] approved the trial and study on 09-02-2017 following the opinion of its ethics committee, Comissão de Ética para a Saúde of ARS Centro on 01-02-2017. The ethics committee Instituto de Bioética of Universidade Católica Portuguesa also approved the study (Ethical Screening Report 02/2018) on 20-03-2018. In early 2018, we revised all data protection procedures to meet the new General Data Protection Regulation (GDPR) entering into force on 25 May 2018 and we detailed these in the Privacy Impact Assessment of the trial on 28-02-2018 which was provided to both Ethics Committees. Participants provided written consent. Consent Forms included provisions for collecting economic data and consent for the DCE study was reconfirmed at the end of the trial just before the DCE survey.